
In Canada, cannabis producers are adopting transparent packaging to increase consumer confidence, differentiate themselves from the conventional industry, and reinforce product quality

New partnerships with insurers and healthcare systems aim to facilitate clinically oriented treatments for millions of Americans

Amid tensions with Trump, Gustavo Petro suggests drug policy change and cannabis exports

New legislation redefines hemp and prohibits most broad-spectrum CBD products starting in 2026

Ayr Wellness' restructuring plan exposes financial fragility of cannabis operators in the United States

The longest strike in the United States cannabis industry came to an end after 45 days, with victory for Green Thumb Industries workers

Category grows 12% annually and already represents 15.4% of the total cannabis market in the United States

Business of Cannabis: New York 2025 will bring together investors, regulators, and industry leaders to discuss the future of cannabis in the United States, focusing on innovation, sustainability, and regulation

In a press conference, the Venezuelan president states that the country will not follow the "insane trend" of legalizing drugs and points to the production of "synthetic super marijuana" in the United States

While the US seeks to include medicinal cannabis in insurance coverage, Brazil advances through state laws and judicial decisions for access to treatment

The search for relief from chronic pain and sleep disorders reveals a cultural and therapeutic shift among the elderly

Proposal redefining limits and banning derivatives with total THC advances in the Senate with White House support

Organizations are pressuring President Trump to legalize marijuana in the US, going beyond mere rescheduling and seeking to repair the damages of historical prohibition

Experts point out that federal legalization could open doors for national trademarks, but obstacles still persist

The Australian medicinal cannabis market is consolidating as an international reference and inspiring discussions in Brazil

The US Department of Defense will start testing military personnel for psilocybin, a psychedelic substance found in mushrooms, aiming at the safety, discipline, and readiness of the armed forces

The Trump administration is considering reclassifying marijuana as a lower-risk drug, a move that would facilitate research, investments, and tax deductions for the sector

Large-scale study funded by the US government reveals that older adults who use cannabis have superior brain performance and possible neuroprotective benefits

New spending law in the US, which ended the shutdown, may impact the market of psychoactive hemp derivatives

How college students are (supposedly) using marijuana to enhance focus, creativity, and combat academic stress